• Latest Posts

Eli Lilly Offers German Biotech up to €1.5Bn to Develop mRNA Cancer Vaccines

Eli Lilly Partners with German Biotech Against Autoimmune Disease

More News! 18 Aug 2017

Novo Nordisk’s New Type 2 Diabetes Drug Outperforms Eli Lilly’s

German Biotech Unveils Positive Phase II Results for Alzheimer’s

Bad News for Diabetics: Eli Lilly Abandons French Ultra-Rapid Insulin

The 8 Biggest Biotech Medical Fails of 2016 in Europe


Following Eli Lilly’s Failure, what’s Next in Alzheimer’s Treatments?

Results from 45% of Clinical Trials are kept Secret

Biotech Environment in 2016: Reverse Engineering the Ecosystem #BES2016

A Relief for Migraines at last? The Biotech race for the Ultimate Cure

Also Using PD-L1 Cancer Treatments to Attack Alzheimer’s Disease

This French Biotech has a ‘Super-Insulin’ up its Diabetes Sleeve